| [1] |
叶海东, 刘 宇, 甄朋超. 苍术素调节PINK1/Parkin信号通路对膝骨关节炎大鼠线粒体自噬的影响[J]. 微循环学杂志, 2023, 33(4): 13-20.
|
| [2] |
陈后煌. 从Ras-Raf-MEK1/2-ERK1/2信号通路探讨电针干预膝骨关节炎软骨退变的机制[D]. 福州: 福建中医药大学, 2017.
|
| [3] |
曾国际, 郭夕语, 李 雨, 等. 基于虚拟现实技术的康复训练对膝骨关节炎患者康复的研究进展[J]. 风湿病与关节炎, 2023, 12(10): 61-5.
|
| [4] |
Lv Z, Yang YX, Li J, et al. Molecular classification of knee osteoarthritis[J]. Front Cell Dev Biol, 2021, 9: 725568. doi:10.3389/fcell.2021.725568
|
| [5] |
Asehnoune K, Strassheim D, Mitra S, et al. Involvement of reactive oxygen species in Toll-like receptor 4-dependent activation of NF-kappa B[J]. J Immunol, 2004, 172(4): 2522-9. doi:10.4049/jimmunol.172.4.2522
|
| [6] |
Baldwin AS. Series introduction: the transcription factor NF-kappaB and human disease[J]. J Clin Invest, 2001, 107(1): 3-6. doi:10.1172/jci11891
|
| [7] |
Ghosh S, Hayden MS. New regulators of NF-kappaB in inflammation[J]. Nat Rev Immunol, 2008, 8(11): 837-48. doi:10.1038/nri2423
|
| [8] |
Nagumo Y, Kandori S, Tanuma K, et al. PLD1 promotes tumor invasion by regulation of MMP-13 expression via NF-κB signaling in bladder cancer[J]. Cancer Lett, 2021, 511: 15-25. doi:10.1016/j.canlet.2021.04.014
|
| [9] |
朱 媛, 王亚琴. 桃叶珊瑚苷的研究进展[J]. 中草药, 2006, 37(6): 947-9.
|
| [10] |
卢仁睿, 张 莉, 王慧慧, 等. 桃叶珊瑚苷通过调节小胶质细胞M1/M2极化抑制神经炎症[J]. 中国新药杂志, 2023, 32(9): 934-40.
|
| [11] |
刁玮琳, 尹 敏, 李 翠. 桃叶珊瑚苷在烟曲霉菌角膜炎中抗炎作用及其机制[J]. 青岛大学学报: 医学版, 2023, 59(4): 501-6.
|
| [12] |
钟子安, 刘 娟, 杨 柳, 等. 基于Nox4/NLRP3通路探讨桃叶珊瑚苷干预动脉粥样硬化的作用机制[J]. 中西医结合心脑血管病杂志, 2023, 21(13): 2405-11.
|
| [13] |
杨 雷, 李兆勇, 马 露, 等. 基于TLR4/NF-κB通路研究桃叶珊瑚苷联合ADSCs-exos对TBHP诱导的髓核细胞保护作用[J]. 中国中药杂志, 2023, 48(19): 5294-303.
|
| [14] |
Wang SN, Xie GP, Qin CH, et al. Aucubin prevents interleukin-1 beta induced inflammation and cartilage matrix degradation via inhibition of NF-κB signaling pathway in rat articular chondrocytes[J]. Int Immunopharmacol, 2015, 24(2): 408-15. doi:10.1016/j.intimp.2014.12.029
|
| [15] |
Endisha H, Datta P, Sharma A, et al. microRNA-34a-5p promotes joint destruction during osteoarthritis[J]. Arthritis Rheumatol, 2021, 73(3): 426-39. doi:10.1002/art.41552
|
| [16] |
Wu Y, Li J, Zeng Y, et al. Exosomes rewire the cartilage microenvironment in osteoarthritis: from intercellular communi-cation to therapeutic strategies[J]. Int J Oral Sci, 2022, 14(1): 40. doi:10.1038/s41368-022-00187-z
|
| [17] |
Wang CJ, Sun YC, Siu KK, et al. Extracorporeal shockwave therapy shows site-specific effects in osteoarthritis of the knee in rats[J]. J Surg Res, 2013, 183(2): 612-9. doi:10.1016/j.jss.2013.02.006
|
| [18] |
Ding H, Wei J, Zhao Y, et al. Progranulin derived engineered protein Atsttrin suppresses TNF-α-mediated inflammation in intervertebral disc degenerative disease[J]. Oncotarget, 2017, 8(65): 109692-702. doi:10.18632/oncotarget.22766
|
| [19] |
Phillips R. Targeting articular Mmp13 in OA[J]. Nat Rev Rheumatol, 2021, 17(11): 645. doi:10.1038/s41584-021-00696-x
|
| [20] |
Kim HH, Kim K. Enhancement of TNF-α-mediated cell death in vascular smooth muscle cells through cytochrome c-independent pathway by the proteasome inhibitor[J]. FEBS Lett, 2003, 535(1/2/3): 190-4. doi:10.1016/s0014-5793(02)03894-2
|
| [21] |
Li JJ, Johnson AR. Selective MMP13 inhibitors[J]. Med Res Rev, 2011, 31(6): 863-94. doi:10.1002/med.20204
|
| [22] |
Etoh T, Inoue H, Yoshikawa Y, et al. Increased expression of collagenase-3 (MMP-13) and MT1-MMP in oesophageal cancer is related to cancer aggressiveness[J]. Gut, 2000, 47(1): 50-6. doi:10.1136/gut.47.1.50
|
| [23] |
Geng R, Li J, Yu C, et al. Knee osteoarthritis: Current status and research progress in treatment (Review)[J]. Exp Ther Med, 2023, 26(4): 481. doi:10.3892/etm.2023.12180
|
| [24] |
Song X, Liu Y, Chen S, et al. Knee osteoarthritis: a review of animal models and intervention of traditional Chinese medicine[J]. Animal Model Exp Med, 2024, 7(2): 114-26. doi:10.1002/ame2.12389
|
| [25] |
Mahida JP, Antczak C, Decarlo D, et al. A synergetic screening approach with companion effector for combination therapy: application to retinoblastoma[J]. PLoS One, 2013, 8(3): e59156. doi:10.1371/journal.pone.0059156
|
| [26] |
Ben-Neriah Y, Karin M. Inflammation meets cancer, with NF-κB as the matchmaker[J]. Nat Immunol, 2011, 12(8): 715-23. doi:10.1038/ni.2060
|
| [27] |
Natoli G, Chiocca S. Nuclear ubiquitin ligases, NF-κB degradation, and the control of inflammation[J]. Sci Signal, 2008, 1(1): 1103-12. doi:10.1126/stke.11pe1
|
| [28] |
Zhong ZY, Umemura A, Sanchez-Lopez E, et al. NF-κB restricts inflammasome activation via elimination of damaged mitochondria[J]. Cell, 2016, 164(5): 896-910. doi:10.1016/j.cell.2015.12.057
|
| [29] |
Xie ZB, Chen KM, Huang CW, et al. Correlation between macrophage chemotaxis and disease severity in patients with knee osteoarthritis[J]. Zhongguo Gu Shang, 2023, 36(6): 514-8.
|